Active Biotech management team consist of Helen Tuvesson, President & CEO, Hans Kolam, Chief Financial Officer and Helena Eriksson, Chief Scientific Officer.

Helén Tuvesson

President & CEO

Born 1962
Shareholding: 11 892 shares

Helén Tuvesson was employed in Active Biotech in 1998. Helén Tuvesson has a PhD in medical science from Lund University. She has extensive experience in drug development after more than 20 years on senior positions within Pharmacia and Active Biotech, most recently as responsible for the company’s research and development.

Hans Kolam

Chief Financial Officer

Born 1951
Shareholding: 53 461 shares (of which 3 696 shares via related parties)

Hans Kolam has worked for Active Biotech since 2000. He has more than 35 years’ experience in the pharmaceuticals industry, holding different positions in Pharmacia’s financial organisation, most recently as Vice President of Finance, Europe.

Helena Eriksson

Chief Scientific Officer

Born 1968
Shareholding: 3 294 shares

Helena Eriksson was employed in Active Biotech in 1998. Helena Eriksson has a PhD in experimental hematology from Lund University. She has more than 20 years’ experience in the pharmaceutical industry, most recently as Director of BioScience and Project Manager at Active Biotech.